AnovoRx Appoints Steve Fitzpatrick as Chief Executive Officer
AnovoRx Holding, LLC (“Anovo”), a leading provider of specialty pharmacy services and customized treatment and support programs that address the unique needs of patients with complex and chronic diseases, today announced the appointment of Steve Fitzpatrick as Chief Executive Officer, effective March 9, 2026.
